Gilbert Lefèvre

2.2k citations

52 papers · 1.5k indexed · h-index 21

Impact in

Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
- Drug-Induced Hepatotoxicity and Protection
Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery

Papers in

Pharmacology 11
- Cholinesterase and Neurodegenerative Diseases 9
- Drug-Induced Hepatotoxicity and Protection 8
- Pharmacogenetics and Drug Metabolism 5
Public Health, Environmental and Occupational Health 23
- Malaria Research and Control 22
- Mosquito-borne diseases and control 7

Co-authors: Abdoulaye Djimdé Silke Appel‐Dingemanse Heinz Schmidli Alexander Kurz Martin R. Farlow Jay Prakash Jain G Sędek Thierry T. Diagana
Journals: Malaria Journal (7 papers)The Journal of Clinical Pharmacology (7 papers)Antimicrobial Agents and Chemotherapy (4 papers)American Journal of Tropical Medicine and Hygiene (3 papers)Neurology (2 papers)
Partner nations: Switzerland United States France

In The Last Decade

Gilbert Lefèvre

50 papers receiving 1.4k citations

Peers

Countries citing papers authored by Gilbert Lefèvre

Since Specialization

Citations

This map shows the geographic impact of Gilbert Lefèvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert Lefèvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert Lefèvre more than expected).

Fields of papers citing papers by Gilbert Lefèvre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert Lefèvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert Lefèvre. The network helps show where Gilbert Lefèvre may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gilbert Lefèvre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gilbert Lefèvre Line = papers co-authored together Gilbert Lefèvre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In situ determination of 2D spatially-resolved size distribution of soot aggregates in a laminar diffusion flame Proceedings of the Combustion Institute ·sensory input to the central nervous system, Gilbert Lefèvre, S. N. Trunova, Andrés Fuentes, Jérôme Yon	2025	1
2	Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®) Malaria Journal ·Alfred B. Tiono, Halidou Tinto, Yago Vinícius Pereira, Martin Meremikwu, Antoinette Tshefu, Bernhards Ogutu, Alphonse Ouédraogo, Moussa Lingani, Marc Cousin, Gilbert Lefèvre, Jay Prakash Jain, Stephan Duparc, Kamal Hamed	2015	8
3	Spiroindolone KAE609 for Falciparum and Vivax Malaria New England Journal of Medicine ·Nicholas J. White, Sasithon Pukrittayakamee, Aung Pyae Phyo, Ronnatrai Rueangweerayut, François Nosten, Podjanee Jittamala, Atthanee Jeeyapant, Jay Prakash Jain, Gilbert Lefèvre, Ruobing Li, Baldur Magnusson, Thierry T. Diagana, F. Joel Leong	2014	163
4	Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem®) for bioequivalence in a randomized, open-label, two-period study Malaria Journal ·Gilbert Lefèvre, J G Van Den Broek, Jay Prakash Jain, 엄진업, Yi Cheng, Luis Pelegrino J, Daniel S. Stein	2013	11
5	Lower artemether, dihydroartemisinin and lumefantrine concentrations during rifampicin-based tuberculosis treatment AIDS ·Mohammed Lamorde, Pauline Byakika‐Kibwika, Jonathan Mayito, Tita Shipuh Victor Mbanya, Máirín Ryan, Warunee Hanpithakpong, Gilbert Lefèvre, David Back, Saye Khoo, Concepta Merry	2012	12
6	Randomized, Prospective, Three-Arm Study to Confirm the Auditory Safety and Efficacy of Artemether-Lumefantrine in Colombian Patients with Uncomplicated Plasmodium falciparum Malaria American Journal of Tropical Medicine and Hygiene ·Gabriel Carrasquilla, Chrystler T. Orbien, Edwin M. Monsell, Marc Cousin, Verena Walter, Gilbert Lefèvre, Oliver Sander, Laurel M. Fisher	2012	20
7	Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria Annals of the New York Academy of Sciences ·Gilbert Lefèvre, รัตนาวดี เถกิงสุขวัฒนา, Lars Åke Janzon	2011	6
8	Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria Antimicrobial Agents and Chemotherapy ·Abdoulaye Djimdé, Mamadou Teketé, Salim Abdulla, Hanhan Zhou, Quique Bassat, Inácio Mandomando, Gilbert Lefèvre, Steffen Borrmann, (unknown)	2011	22
9	Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjects Malaria Journal ·Salim Abdulla, Mbaraka Amuri, Abdunoor M. Kabanywanyi, David Ubben, Christine Reynolds, Steve Pascoe, Serge Fitoussi, Ching‐Ming Yeh, Е А Ярушкина, Romain Séchaud, G. Kaiser, Gilbert Lefèvre	2010	21
10	The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem^®) for acute uncomplicatedPlasmodium falciparummalaria Tropical Medicine & International Health ·Steffen Borrmann, William M. Sallas, Sónia Machevo, Raquel González, Anders Björkman, Andreas Mårtensson, Mary J. Hamel, Elizabeth Juma, Judy Peshu, Bernhards Ogutu, Abdoulaye Djimdé, Umberto D’Alessandro, NI Xiaoshan, Gilbert Lefèvre, Steven E. Kern	2010	43
11	Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review International Journal of Clinical Practice ·Alexander Kurz, Martin R. Farlow, Gilbert Lefèvre	2009	110
12	Understanding the pharmacokinetics of Coartem® Malaria Journal ·Abdoulaye Djimdé, Gilbert Lefèvre	2009	89
13	Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer’s Disease Not Affected by Co-Administration of Memantine Clinical Drug Investigation ·Joshua R. Shua‐Haim, Calistro Ximenes de Deus, Franck Picard, G Sędek, طارق مهدى, F. Pommier, Gilbert Lefèvre	2008	20
14	Pharmacokinetics and Bioavailability of the Novel Rivastigmine Transdermal Patch Versus Rivastigmine Oral Solution in Healthy Elderly Subjects The Journal of Clinical Pharmacology ·Gilbert Lefèvre, F. Pommier, G Sędek, Mark Allison, Carlos García-Ausencio, Beate Kiese, J RMIKLOS, Silke Appel‐Dingemanse	2008	35
15	Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application The Journal of Clinical Pharmacology ·Gilbert Lefèvre, G Sędek, Carlos García-Ausencio, Marc Saltzman, Mitchell Rosenberg, Beate Kiese, Peter J. Fordham	2007	50
16	Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients Clinical Pharmacology & Therapeutics ·Gilbert Lefèvre, G Sędek, S. S. Jhee, Mark Leibowitz, Jeffery S. Bourgeois, Albert Enz, Martín Goycoechea Menéndez, Larry Ereshefsky, F. Pommier, Heinz Schmidli, Silke Appel‐Dingemanse	2007	106
17	Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants. American Journal of Tropical Medicine and Hygiene ·Azran Fitri Rahim, Gilbert Lefèvre, P.H. Degen, A. Sioufi	2002	28
18	Pharmacokinetics and electrocardiographic pharmacodynamics of artemether‐lumefantrine (Riamet^®) with concomitant administration of ketoconazole in healthy subjects British Journal of Clinical Pharmacology ·Gilbert Lefèvre, Piero A. Verona, C. Souppart, Heinz Schmidli, T. I. Yarmola, Daria Stypinski	2002	63
19	Immunoassays in Monitoring Biotechnological Drugs Therapeutic Drug Monitoring ·Daniel Gygax, L Botta, Markus Ehrat, Peter Gräf, Gilbert Lefèvre, Peter Oroszlán, C. Pfister	1996	10
20	Anti-idiotypic antibodies to a monoclonal antibody raised against anti-Müllerian hormone exhibit anti-Müllerian biological activity Molecular and Cellular Endocrinology ·Gilbert Lefèvre, Dien Tran, Johan Hoebeke, Lian Juan	1989	2

About Gilbert Lefèvre

Gilbert Lefèvre is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health, Computational Theory and Mathematics, Pharmacology and Complementary and alternative medicine, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Malaria Research and Control (22 papers), Computational Drug Discovery Methods (12 papers), Cholinesterase and Neurodegenerative Diseases (9 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Mosquito-borne diseases and control (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Pharmacology (272 citations), Pharmaceutical Science (140 citations), Public Health, Environmental and Occupational Health (666 citations), Pharmacology (350 citations) and Computational Theory and Mathematics (273 citations). Gilbert Lefèvre has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Abdoulaye Djimdé, Silke Appel‐Dingemanse, Heinz Schmidli, Alexander Kurz, Martin R. Farlow, Jay Prakash Jain, G Sędek, Thierry T. Diagana, Baldur Magnusson and Ruobing Li. Their work appears in journals such as Malaria Journal, The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, American Journal of Tropical Medicine and Hygiene and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact